Everolimus in kidney transplantation

Everolimus in kidney transplantation

James E Cooper&sup1;, Uwe Christians&sup2;, Alexander C Wiseman&sup1;&sup1;Division of Renal Diseases and Hypertension, Transplant Center, &sup2;iC42 Integrated Solutions in Systems Biology for Clinical Research and Development, University of Colorado Denver,...

Full description

Bibliographic Details
Main Authors:	Cooper JE, Christians U, Wiseman AC
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-07-01
Series:	Transplant Research and Risk Management
Online Access:	http://www.dovepress.com/everolimus-in-kidney-transplantation-a7829

Similar Items

EVEROLIMUS FOR KAPOSI'S SARCOMA TREATMENT AFTER KIDNEY TRANSPLANTATION
by: I. V. Alexandrov, et al.
Published: (2015-05-01)

Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus
by: Lucía Ordóñez-Fernández, et al.
Published: (2019-03-01)

THE USE OF EVEROLIMUS IN KIDNEY TRANSPLANTATION FROM EXPANDED CRITERIA DONORS
by: I. V. Ulyankina, et al.
Published: (2009-06-01)

Efficacy of everolimus in ABO-incompatible kidney transplantation: a retrospective study
by: Tsujimura K, et al.
Published: (2017-09-01)

The role of everolimus in liver transplantation
by: Ganschow R, et al.
Published: (2014-09-01)

Everolimus in Heart Transplantation: An Update
by: Stephan W. Hirt, et al.
Published: (2013-01-01)

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01)

Analysis of early use of everolimus with low-dose calcineurin inhibitors in kidney transplant recipient
by: I. G. Kim, et al.
Published: (2019-10-01)

The use of everolimus in renal-transplant patients
by: Julio Pascual
Published: (2009-06-01)

Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen
by: Stephan Ruben, et al.
Published: (2018-05-01)

Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
by: Viola Menghi, et al.
Published: (2016-01-01)

EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
by: E. I. Prokopenko
Published: (2010-06-01)

Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials.
by: Jinyu Liu, et al.
Published: (2017-01-01)

Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients
by: Larissa Sgaria Pacheco, et al.
Published: (2018-05-01)

Pharmacoeconomic analysis of everolimus immunosuppressive therapy for <i>de novo</i> kidney transplant recipients in Russia
by: N. A. Avxentyev, et al.
Published: (2019-05-01)

Long-term outcome of everolimus treatment in transplant patients
by: Salvadori M, et al.
Published: (2011-05-01)

P-102 EVEROLIMUS IN RENAL DYSFUNCTION IN LIVER TRANSPLANTATION
by: Carolina Salinas, et al.
Published: (2021-09-01)

TRANSFORM: a novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation
by: Pascual J, et al.
Published: (2014-06-01)

Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation
by: Phillip Lo, MD, MMed, et al.
Published: (2020-09-01)

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015-06-01)

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
by: Claudia Sommerer, et al.
Published: (2018-09-01)

Conversion to everolimus to preserve kidney function in a heart transplant recipient, a personalized approach of immunos uppressive therapy
by: N. N. Koloskova, et al.
Published: (2018-09-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Critical appraisal on the use of everolimus in renal transplantation as an immunosuppressant to prevent organ transplant rejection
by: Fernando Giron, et al.
Published: (2010-01-01)

An acute episode of rhabdomyolysis associated with everolimus and cabergoline intake in a postpartum kidney recipient
by: B. I. Yaremin, et al.
Published: (2017-12-01)

Everolimus-associated acute kidney injury in patients with metastatic breast cancer
by: A Chandra, et al.
Published: (2017-01-01)

EARLY CONVERSION TO EVEROLIMUS IN RECIPIENTS OF KIDNEYS FROM EXPANDED CRITERIA DONORS
by: O. N. Reznik, et al.
Published: (2010-06-01)

The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
by: Hallvard Holdaas, et al.
Published: (2016-01-01)

Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
by: Alexander Chehrazi-Raffle, et al.
Published: (2020-06-01)

Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).
by: Susanne Brakemeier, et al.
Published: (2019-01-01)

Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantation
by: Ramy M Hanna, et al.
Published: (2019-01-01)

Everolimus and papillomavirus lesions in female renal transplant recipient: A case report
by: T. Simundic, et al.
Published: (2018-08-01)

Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
by: Uwe Fuchs, et al.
Published: (2012-01-01)

Everolimus in clinical practice after liver transplantation: a single-center experience
by: O. A. Gerasimova, et al.
Published: (2017-06-01)

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
by: Ute Eisenberger, et al.
Published: (2018-06-01)

Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
by: Serena Patel, et al.
Published: (2018-01-01)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
by: Sebastian C. B. Bremer, et al.
Published: (2018-11-01)